The stock price of Coherus Biosciences (CHRS) is predicted to experience a bearish trend tomorrow, May 18, 2025. Here's a detailed analysis to support this conclusion:
- Current Price Trend: The stock is currently between narrow resistance and wide resistance levels, indicating a price trend that is likely to face downward pressure.
- Forecasted Price Trend: The forecast for CHRS's price trend is bearish, with a sell advice and a historical win rate of 53.08% for this type of forecast.
- Support and Resistance Levels: The stock is positioned between narrow and wide resistance levels, which suggests that the price is more likely to experience a pullback towards the lower end of this range.
- Recent Performance: CHRS has seen a bullish trend in the short term, but this has been accompanied by increasing volatility. The stock's recent peak at $1.11 on April 17, 2025, may be poised for a correction downward1.
- Market Sentiment: Despite the positive sentiment surrounding the company's recent divestiture and strategic transformation, the stock price is expected to face downward pressure due to the bearish forecast and the current price trend.
In conclusion, the combination of the bearish forecast, the current price trend, and the resistance levels suggest that CHRS's stock price is more likely to decline than to rise tomorrow.